COVID-19: Washington To Support GSK, Sanofi Vaccine With $2.1bn

COVID-19: Washington To Support GSK, Sanofi Vaccine With $2.1bn


GlaxoSmithKline and Sanofi have inked an agreement with the US government to speed up the development and manufacturing of their Covid-19 vaccine candidate at scale. Washington will provide up to $2.1bn under the aegis of the Trump administration’s Warp Speed operation, with more than half of the monies to be funnelled into support for developing the vaccine and […]



Source link

Leave a Reply

Close Menu